- House overwhelmingly approves $16 billion cash infusion for VA overhaul
- Obama admin to blame for HealthCare.gov woes, $840M cost: GAO
- Al Gore’s climate-changers at EPA hearings foiled by cool temperatures
- Army’s 3-D printed bombs will create ‘a whole new universe’ of deadly capabilities
- Hamas calls on Hezbollah to join in fight against Israel
- Senators to FIFA, others: Don’t reward Putin with the World Cup in 2018
- U.S. condemns shelling of U.N. school in Gaza
- Obamacare shoots premiums up by 88 percent in California
- Chicken pox outbreak puts illegal immigrant facility on lockdown
- Obama to Republicans: ‘Stop just hatin’ all the time’
By Ted Cruz
Israel saves its enemies; Hamas endangers its friends
Topic - John Castellani
The chief spokesman for pharmaceutical manufacturers says President Obama has stuck two thorns in the industry's side at a time marked by uncertainty as lawmakers contemplate cutting health care programs and battles over the new health care law wind their way through the courts.
When the president presented his deficit-cutting plan last week, he included measures that will drive up drug prices and squash investment in companies that develop drugs and medical devices, said John Castellani, president of the Pharmaceutical Research and Manufacturers of America (PhRMA).
But when it comes to policy, he said, Mr. Obama doesn't understand the industry's "core" needs.